Myocardial contrast echoperfusion versus FFR for the assessment of LAD disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004697

Enrollment

Registered

2013-07-08

Start date

2013-08-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I25

Interventions

Group 1: Non intervention study assessing myocardial contrast perfusion with echocardiography while infusing adenosine for assessing FFR of Left anterior descending artery

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients referred for FFR assessment of the LAD disease

Exclusion criteria

Exclusion criteria: Patients with contraindications to Adenosine Patients with contraindications to Sulphur (used in the contrast agent for echocardiogrpahy) Patients with poor echo window defined as incomplete visualization of the endo-epicardium Patients becoming unwell during the FFR procedure

Design outcomes

Primary

Measure	Time frame
Correlation between Myocardial contrast echo perfusion results and Fractional flow reserve results	—

Secondary

Measure	Time frame
Correlation between Myocardial contrast echoperfusion results and the % angiographic diameter stenosis. Correlation between myocardial contrast echo perfusion results and regional wall motion abnormalities	—

Countries

United Kingdom

Contacts

Public ContactAhmed Farag

Chief investigator

ahmedkf80@gmail.com00447587205281

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026